Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
A blueprint for improving the promotion and delivery of adult vaccination in the United States / / Katherine M. Harris ... [et al.]
| A blueprint for improving the promotion and delivery of adult vaccination in the United States / / Katherine M. Harris ... [et al.] |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Santa Monica, Calif., : RAND Health, 2012 |
| Descrizione fisica | 1 online resource (55 p.) |
| Disciplina | 614.470973 |
| Altri autori (Persone) | HarrisKatherine M |
| Soggetto topico |
Vaccination - United States
Health attitudes - United States Health promotion - United States Health surveys - United States Health behavior - United States |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title Page; Copyright; Preface; Contents; Figures; Tables; Summary; Acknowledgments; Chapter One: Introduction; Chapter Two: Findings; Low Adult Vaccination Rates Lead to Costly and Avoidable Illnesses; The Policy and Practice Environment Surrounding Adult Vaccination Is Changing Rapidly; 2.1. Burdens of Selected Vaccine-Preventable Diseases and Benefits of Vaccination; 2.2. Selected Adult Vaccination Rates by Recommended Subgroup; 2.3. Healthy People Objectives Specific to Adult Vaccination, Targets and 2008 Baseline
2.4. Location of Seasonal Influenza Vaccination (2009-2010) by Age and RaceOffice-Based Settings Are a Logical Focus of Efforts to Increase Adult Vaccination; 2.1. Vaccination Status of U.S. Adults Recommended for Influenza Vaccination by ACIP, March 2009; 2.2. Influenza Vaccination Rates and Location of Vaccination by Influenza Season; 2.5. Percentage of Physicians Administering Adult Vaccinations by Vaccine Type, Physician Specialty, and Data Collection Method; Office-Based Health Care Providers Are Not Meeting Their Potential in Promoting Adult Vaccination 2.6. Percentage of Survey Respondents Indicating That Statements About the Safety of Influenza Vaccination Made Them More ComfortableEconomic Barriers Prevent Office-Based Adult Vaccination from Reaching Pediatric Levels; 2.3. Intentions to Be Vaccinated for Flu by Concerns About Flu Vaccine Safety, 2010; 2.4. Percentage of Respondents Intending to Be Vaccinated for Influenza by Worry About Getting Influenza and Beliefs About Whether Influenza Vaccination Causes Influenza; Encouraging Practice Change Around Adult Vaccination; Chapter Three: Recommendations Chapter Four: Conclusions and Policy ImplicationsReferences |
| Record Nr. | UNINA-9910219982303321 |
| Santa Monica, Calif., : RAND Health, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Confronting a growing public health threat : measles outbreaks in the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, February 27, 2019
| Confronting a growing public health threat : measles outbreaks in the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, February 27, 2019 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2020 |
| Descrizione fisica | 1 online resource (v, 84 pages) : illustrations |
| Soggetto topico |
Measles - United States
Communicable diseases - United States - Prevention Immunization - United States Vaccination - United States Communicable diseases - Prevention Immunization Measles Vaccination |
| Soggetto genere / forma | Legislative hearings. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Confronting a Growing Public Health Threat |
| Record Nr. | UNINA-9910714768503321 |
| Washington : , : U.S. Government Publishing Office, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diseases of importance in developing countries [[electronic resource] ] : establishing priorities / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine
| Diseases of importance in developing countries [[electronic resource] ] : establishing priorities / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1986 |
| Descrizione fisica | 1 online resource (448 p.) |
| Collana | New vaccine development |
| Soggetto topico |
Vaccination - Developing countries
Vaccination - United States Vaccines - Research - Government policy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-22176-3
9786610221769 0-309-56820-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456440603321 |
| Washington, D.C., : National Academy Press, 1986 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diseases of importance in developing countries : establishing priorities / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine
| Diseases of importance in developing countries : establishing priorities / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C. : , : National Academy Press, , 1986 |
| Descrizione fisica | 1 online resource (xvi, 432 pages) |
| Collana | New vaccine development |
| Soggetto topico |
Vaccination - Developing countries
Vaccination - United States Vaccines - Research - Government policy |
| ISBN |
1-280-22176-3
9786610221769 0-309-56820-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910780010703321 |
| Washington, D.C. : , : National Academy Press, , 1986 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diseases of importance in the United States [[electronic resource] /] / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine
| Diseases of importance in the United States [[electronic resource] /] / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1985 |
| Descrizione fisica | 1 online resource (472 p.) |
| Disciplina | 614.4/7/0973 |
| Collana | New vaccine development : establishing priorities |
| Soggetto topico |
Vaccines - Research - Government policy
Vaccination - United States Vaccination - Developing countries |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-30039-X
9786611300395 0-309-11575-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Title""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Abstract""; ""Contents""; ""1 Summary""; ""Selection of Candidates""; ""Determination of Health Benefits""; ""Disease Burden Estimates""; ""Infant Mortality Equivalence Values""; ""Total Disease Burden Values""; ""Vaccine Characteristics""; ""Predictions of Vaccine Development""; ""Definition of Probable Vaccine Target Population""; ""Estimation of Vaccine Utilization""; ""Estimation of Time to Licensure, Time to vaccine Adoption, and Delay of Vaccination Benefits: Discounting""; ""Estimation of vaccine Preventable Illness""
""Calculation of Expected Health Benefits for Each Vaccine""""Cost Calculations""; ""Calculation of Morbidity Costs Averted by the Vaccine""; ""Vaccination Program Costs""; ""Integration of Costs""; ""Interpretation of Health Benefit and Net Cost Rankings""; ""Findings, Conclusions, Recommendations""; ""Recommendation""; ""Reference""; ""2 Priority Setting for Health Related Investments: A Review of Methods""; ""Methods for Project Ranking and Selection""; ""Multiattribute Accounting""; ""Multiattribute Scoring""; ""Decision Analysis With Multiple Objectives"" ""Cost-Effectiveness and Cost-Utility Analysis""""Benefit-Cost Analysis""; ""Selection of an Approach""; ""Issues in Project Ranking Methodologies""; ""Sources of Estimates""; ""Sequential or “Lexicographic� Methods""; ""Interdependence Among Projects""; ""The “Portfolio� Question""; ""Summary""; ""References""; ""3 Overview of the Analytic Approach""; ""Method""; ""Interpretation of Results""; ""Guidelines""; ""Definition of Dominance""; ""Step 1""; ""Step 2""; ""Step 3""; ""Step 4""; ""Summary""; ""4 Comparison of Disease Burdens and Costs"" ""Elements of the System for Comparing Morbidity and Mortality Burdens Arising From various Diseases""""Trade-Off Values""; ""Expression of Morbidity and Mortality Burdens""; ""Procedures Used in Deriving Disease Estimates""; ""Limitations of the Current Estimates""; ""Value Judgments in Quantifying Morbidity and Mortality""; ""IME Perspectives used in This Study""; ""The Effect of Adopting Other IME Perspectives""; ""Comparison of Direct Costs Resulting from Diseases""; ""Scope of Cost Calculations""; ""Procedures""; ""Findings""; ""Limitations of the Proposed System"" ""Summary and Conclusions""""Recommendations""; ""References""; ""5 Predictions on Vaccine Development""; ""The Need for Predictions""; ""Selection of Candidates""; ""Vaccine Candidates and Target Populations""; ""Predictions on Vaccine Development""; ""Probability of Successful Development""; ""Cost of Development""; ""Time to Licensure""; ""Comments""; ""Predictions on Vaccine Characteristics""; ""Efficacy""; ""Adverse Reactions""; ""Production Technology, Delivery Requirements, and Cost/Dose""; ""Number of Doses and Route of Administration""; ""Conclusions"" ""6 Assessing the Likely Utilization of New Vaccines"" |
| Record Nr. | UNINA-9910456246503321 |
| Washington, D.C., : National Academy Press, 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Diseases of importance in the United States / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine
| Diseases of importance in the United States / / by the Committee on Issues and Priorities for New Vaccine Development, Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1985 |
| Descrizione fisica | 1 online resource (472 pages) |
| Disciplina | 614.4/7/0973 |
| Collana | New vaccine development : establishing priorities |
| Soggetto topico |
Vaccines - Research - Government policy
Vaccination - United States Vaccination - Developing countries |
| ISBN |
1-281-30039-X
9786611300395 0-309-11575-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Title""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Abstract""; ""Contents""; ""1 Summary""; ""Selection of Candidates""; ""Determination of Health Benefits""; ""Disease Burden Estimates""; ""Infant Mortality Equivalence Values""; ""Total Disease Burden Values""; ""Vaccine Characteristics""; ""Predictions of Vaccine Development""; ""Definition of Probable Vaccine Target Population""; ""Estimation of Vaccine Utilization""; ""Estimation of Time to Licensure, Time to vaccine Adoption, and Delay of Vaccination Benefits: Discounting""; ""Estimation of vaccine Preventable Illness""
""Calculation of Expected Health Benefits for Each Vaccine"" ""Cost Calculations""; ""Calculation of Morbidity Costs Averted by the Vaccine""; ""Vaccination Program Costs""; ""Integration of Costs""; ""Interpretation of Health Benefit and Net Cost Rankings""; ""Findings, Conclusions, Recommendations""; ""Recommendation""; ""Reference""; ""2 Priority Setting for Health Related Investments: A Review of Methods""; ""Methods for Project Ranking and Selection""; ""Multiattribute Accounting""; ""Multiattribute Scoring""; ""Decision Analysis With Multiple Objectives"" ""Cost-Effectiveness and Cost-Utility Analysis"" ""Benefit-Cost Analysis""; ""Selection of an Approach""; ""Issues in Project Ranking Methodologies""; ""Sources of Estimates""; ""Sequential or 'Lexicographic' Methods""; ""Interdependence Among Projects""; ""The 'Portfolio' Question""; ""Summary""; ""References""; ""3 Overview of the Analytic Approach""; ""Method""; ""Interpretation of Results""; ""Guidelines""; ""Definition of Dominance""; ""Step 1""; ""Step 2""; ""Step 3""; ""Step 4""; ""Summary""; ""4 Comparison of Disease Burdens and Costs"" ""Elements of the System for Comparing Morbidity and Mortality Burdens Arising From various Diseases"" ""Trade-Off Values""; ""Expression of Morbidity and Mortality Burdens""; ""Procedures Used in Deriving Disease Estimates""; ""Limitations of the Current Estimates""; ""Value Judgments in Quantifying Morbidity and Mortality""; ""IME Perspectives used in This Study""; ""The Effect of Adopting Other IME Perspectives""; ""Comparison of Direct Costs Resulting from Diseases""; ""Scope of Cost Calculations""; ""Procedures""; ""Findings""; ""Limitations of the Proposed System"" ""Summary and Conclusions"" ""Recommendations""; ""References""; ""5 Predictions on Vaccine Development""; ""The Need for Predictions""; ""Selection of Candidates""; ""Vaccine Candidates and Target Populations""; ""Predictions on Vaccine Development""; ""Probability of Successful Development""; ""Cost of Development""; ""Time to Licensure""; ""Comments""; ""Predictions on Vaccine Characteristics""; ""Efficacy""; ""Adverse Reactions""; ""Production Technology, Delivery Requirements, and Cost/Dose""; ""Number of Doses and Route of Administration""; ""Conclusions""; ""6 Assessing the Likely Utilization of New Vaccines"" |
| Record Nr. | UNINA-9910780901103321 |
| Washington, D.C., : National Academy Press, 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Influenza vaccination in the past 12 months among children aged 6 months-17 years: United States, 2019 / / Lindsey I. Black, Amanda E. Ng, and Benjamin Zablotsky
| Influenza vaccination in the past 12 months among children aged 6 months-17 years: United States, 2019 / / Lindsey I. Black, Amanda E. Ng, and Benjamin Zablotsky |
| Autore | Black Lindsey I. |
| Pubbl/distr/stampa | Hyattsville, MD : , : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, , 2021 |
| Descrizione fisica | 1 online resource (7 pages, 1 unnumbered page) : color illustrations, color map |
| Collana | NCHS data brief |
| Soggetto topico |
Vaccines - United States
Vaccination - United States |
| Soggetto genere / forma | Statistics. |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Influenza vaccination in the past 12 months among children aged 6 months-17 years |
| Record Nr. | UNINA-9910716785903321 |
Black Lindsey I.
|
||
| Hyattsville, MD : , : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Initial guidance for an update of the National Vaccine Plan [[electronic resource] ] : a letter report to the National Vaccine Program Office / / Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
| Initial guidance for an update of the National Vaccine Plan [[electronic resource] ] : a letter report to the National Vaccine Program Office / / Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2008 |
| Descrizione fisica | 1 online resource (39 p.) |
| Disciplina | 614.4 |
| Soggetto topico |
Vaccination - United States
Immunization - United States Communicable diseases - United States - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-281-72684-2
9786611726843 0-309-12199-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Title""; ""Reviewers""; ""Contents""; ""Background""; ""Changes Since 1994""; ""Progress Since 1994""; ""Guidance for Developing a New National Vaccine Plan""; ""Concluding Remarks""; ""Appendix A References""; ""Appendix B Statement of Task""; ""Appendix C Meeting One Agenda""; ""Appendix D 1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes"" |
| Record Nr. | UNINA-9910454353303321 |
| Washington, D.C., : National Academies Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Initial guidance for an update of the National Vaccine Plan [[electronic resource] ] : a letter report to the National Vaccine Program Office / / Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
| Initial guidance for an update of the National Vaccine Plan [[electronic resource] ] : a letter report to the National Vaccine Program Office / / Committee on the Review of Priorities in the National Vaccine Plan, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, D.C., : National Academies Press, 2008 |
| Descrizione fisica | 1 online resource (39 p.) |
| Disciplina | 614.4 |
| Soggetto topico |
Vaccination - United States
Immunization - United States Communicable diseases - United States - Prevention |
| ISBN |
0-309-17876-2
1-281-72684-2 9786611726843 0-309-12199-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Title""; ""Reviewers""; ""Contents""; ""Background""; ""Changes Since 1994""; ""Progress Since 1994""; ""Guidance for Developing a New National Vaccine Plan""; ""Concluding Remarks""; ""Appendix A References""; ""Appendix B Statement of Task""; ""Appendix C Meeting One Agenda""; ""Appendix D 1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes"" |
| Record Nr. | UNINA-9910782762303321 |
| Washington, D.C., : National Academies Press, 2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Long shot [[electronic resource] ] : vaccines for national defense / / Kendall Hoyt
| Long shot [[electronic resource] ] : vaccines for national defense / / Kendall Hoyt |
| Autore | Hoyt Kendall <1971-> |
| Pubbl/distr/stampa | Cambridge, Mass., : Harvard University Press, 2012 |
| Descrizione fisica | 1 online resource (315 p.) |
| Disciplina | 614.4/7 |
| Soggetto topico |
Vaccination - United States
Vaccines - Government policy - United States Biological weapons - Safety measures - Government policy - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-674-06315-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Disease, security, and vaccines -- Historical patterns of vaccine innovation -- Vaccine development during World War II -- Wartime legacies -- The end of an era -- Biodefense in the 21st century -- The search for sustainable solutions. |
| Record Nr. | UNINA-9910457886803321 |
|
Hoyt Kendall <1971->
|
||
| Cambridge, Mass., : Harvard University Press, 2012 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
